MeiraGTx Holdings plc Earnings Per Share (Diluted)
MeiraGTx Holdings plc (MGTX) reported Earnings Per Share (Diluted) of $1.71 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- MeiraGTx Holdings plc earnings per share, diluted for the quarter ending 2026-06-30 was $1.71.
- MeiraGTx Holdings plc earnings per share, diluted for the quarter ending 2026-03-31 was -$0.57.
- MeiraGTx Holdings plc earnings per share, diluted for the quarter ending 2025-09-30 was -$0.62.
- MeiraGTx Holdings plc earnings per share, diluted for the quarter ending 2025-06-30 was -$0.48.
- MeiraGTx Holdings plc earnings per share, diluted for fiscal 2025 was -$1.42.
- MeiraGTx Holdings plc earnings per share, diluted for fiscal 2024 was -$2.12.
- MeiraGTx Holdings plc earnings per share, diluted for fiscal 2023 was -$1.49.
- MeiraGTx Holdings plc earnings per share, diluted for fiscal 2022 was -$2.87.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.71 10-Q · filed 2026-08-13 | $1.30 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | -$0.57 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$1.42 10-K · filed 2026-03-30 | |||
| 2025-09-30 | -$0.62 10-Q · filed 2025-11-13 | -$1.61 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | -$0.48 10-Q · filed 2026-08-13 | -$0.99 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | -$0.51 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$2.12 10-K · filed 2026-03-30 | |||
| 2024-09-30 | -$0.55 10-Q · filed 2025-11-13 | -$1.62 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$0.76 10-Q · filed 2025-08-14 | -$1.08 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$0.32 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | -$1.49 10-K · filed 2025-03-13 | |||
| 2023-09-30 | -$0.74 10-Q · filed 2024-11-13 | -$1.91 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | -$0.53 10-Q · filed 2024-08-12 | -$1.15 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$0.62 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$2.87 10-K · filed 2024-03-15 | |||
| 2022-09-30 | -$0.83 10-Q · filed 2023-11-14 | -$2.29 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$0.76 10-Q · filed 2023-08-10 | -$1.46 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$0.70 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$1.80 10-K · filed 2023-03-14 | |||
| 2021-09-30 | -$0.59 10-Q · filed 2022-11-10 | -$1.58 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.46 10-Q · filed 2022-08-11 | -$0.99 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$0.54 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$1.54 10-K · filed 2022-03-10 | |||
| 2020-09-30 | -$0.17 10-Q · filed 2021-11-10 | -$1.29 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |